Yervoy User Reviews & Ratings
Yervoy has an average rating of 9.5 out of 10 from a total of 2 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Melanoma | 1 reviews for Melanoma | 13 medications | |
| Melanoma, Metastatic | 1 reviews for Melanoma, Metastatic | 14 medications |
- D B...
- Taken for 1 to 6 months
- September 29, 2023
For Melanoma "Developed adrenal insufficiency, but it cured my melanoma."
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about Yervoy (ipilimumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-CTLA-4 monoclonal antibodies
- Breastfeeding
- En español
For Melanoma, Metastatic "Two treatments in combination with OPDIVO, after the first treatment contracted sepsis, close to death but survived, after the second treatment (months apart), contracted colitis, a lot closer to death, told I had 2 days to live - spent 2 weeks in ICU. Six months later, regaining muscle, feeling stronger, cancer still in situ, but hopefully not life-threatening anymore, waiting on the latest PET/CT scans. Possibly keeping me alive, but it takes a toll on your body."